Ethan Wang, MSc, DPhil Candidate
Chief Executive Officer & Co-Founder
Molecular and computational biologist with expertise in cancer genomics, multi-omics integration, and biomarker discovery.
Trained at Johns Hopkins University, UCL Cancer Insitute, Harvard Medical School, and University of Oxford.
Liquid Biopsy
AI
Multi-omics
Branavan Rudran, MBBS, DPhil Candidate
Chief Medical Officer & Co-Founder
Licensed surgeon with expertise in medical imaging technologies. He works at the frontier of medical data analysis and clinical trial design,
bringing deep clinical insight into patient stratification and outcome prediction.
NHS
Medical Translation
Imaging
Dr. Sungyong Kim
Sequencing Scientist
Senior sequencing specialist with 20+ years of experience in next-generation sequencing and immune repertoire analysis. Providing hands-on insights into library preparation, sequencing project design, and high-throughput pipelines.
NGScfDNAImmunology
Serena Qiao, MSc
Software Engineer
A versatile software engineer with experience at Meta, Amazon, and Snowflake. Serena brings deep expertise in cloud application development, translating engineering principles into scalable, production-ready systems.
Software EngineeringDeep LearningCloud Application
Leo Wang, MBA
Financial Advisor
Cambridge EMBA and Global Head at HSBC. Leo brings strong financial acumen and strategic insight to the Totiomics' growth initiatives, combining rigorous analytical thinking with deep knowledge of global markets.
FinanceStrategyInvestment
Catherine Xu, MBA
Investment Advisor
A senior executive with 20+ years in biotech investments. Catherine brings the cross-border transaction expertise and life sciences capital insight that Totiomics needs to scale its technology from bench to international markets.
BiotechInvestmentInternational Operation
Xin Lu
Professor of Cancer Biology
Director of the Ludwig Institute for Cancer Research (Oxford Branch) and Cancer Theme Co-Lead at the NIHR Oxford Biomedical Research Centre, Xin Lu also leads the Oxford Centre for Early Cancer Detection, driving pioneering research in tumour biology and early intervention.
Benjamin Schuster-Böckler
Professor of Computational Genomics
Head of the Computational Genomics Group at the University of Oxford, Benjamin Schuster-Böckler leads research into mutational processes, epigenomics, and cancer evolution, applying computational approaches to uncover the molecular drivers of cancer development.
Richard Owen
Consultant Oesophagogastric Surgeon
Senior Clinical Researcher at the University of Oxford, Richard Owen brings wide-ranging expertise in translational research, transcriptomics, surgical oncology, and clinical trial design, bridging the gap between laboratory discovery and patient care.
Chunxiao Song
Associate Professor of Epigenomics
Based at the Ludwig Institute for Cancer Research, University of Oxford, Chunxiao Song is the pioneer of the TAPS method for base-resolution DNA methylation sequencing, enabling more sensitive and accurate epigenomic profiling in cancer research.
Christopher Yau
Professor of Artificial Intelligence
Professor of Artificial Intelligence at the University of Oxford, Christopher Yau leads research at the intersection of machine learning and genomic medicine, with expertise in probabilistic modelling, single-cell analysis, and AI-driven cancer diagnostics.
Patricia Szajner
Industry & Regulatory Advisor
Assistant Director of the ICCB Screening Facility at Harvard Medical School, Patricia Szajner brings deep expertise in high-throughput screening, drug discovery workflows, and translating cutting-edge research from bench to clinical application.